Morepen Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹484.16 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.63 per cent from ₹411.58 crore. This corresponds to a year-on-year *(YoY) growth of 6.93 per cent.
Operating Profit
Operating Profit stands at ₹46.32 crore, reflecting a quarter-on-quarter *(QoQ) increase of 50.88 per cent from ₹30.70 crore. This corresponds to a year-on-year *(YoY) growth of 28.17 per cent.
PBDT
PBDT stands at ₹45.81 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.59 per cent from ₹56.97 crore. This corresponds to a year-on-year *(YoY) growth of 14.13 per cent.
Profit Before Tax
Profit Before Tax stands at ₹35.43 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.46 per cent from ₹45.69 crore. This corresponds to a year-on-year *(YoY) growth of 0.62 per cent.
Net Profit
Net Profit stands at ₹27.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 32.99 per cent from ₹41.04 crore. This represents a 3.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Morepen Laboratories Ltd News
Morepen Laboratories Ltd Earnings
- YOY
- QOQ
Morepen Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Morepen Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Morepen Laboratories Ltd Financial Reports
Morepen Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Morepen Labs. | -2.19% | -8.24% | 1.48% | 8.26% | -8.26% | -34.13% |
| Unichem Labs. | 1.88% | -2.49% | 7.74% | -0.64% | -22.11% | -38.42% |
| Hikal | -3.17% | -3.65% | 6.89% | -1.92% | -11.88% | -50.15% |
| Panacea Biotec | 0.58% | 1.49% | 13.14% | 9.63% | 2.26% | -27.12% |
| Sai Parenteral's | 0.48% | -1.05% | -1.48% | 18.63% | 18.63% | 18.63% |
| Solara Active | 14.48% | 9.92% | 17.79% | 21.17% | 1.16% | 20.79% |
| Indoco Remedies | -0.49% | 2.58% | 5.14% | 10.75% | -16.63% | -13.76% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Sushil Suri
WTD & Executive Director : Sanjay Suri
Independent Non Exe. Director : Praveen Kumar Dutt
Independent Non Exe. Director : Ranjit Khattar
Independent Non Exe. Director : Savita
Independent Non Exe. Director : Sharad Jain
Company Secretary : Vipul Kumar Srivastava